TRO19622 promotes myelin repair in a rat model of demyelination

International Journal of Neuroscience

Volumn 123, Issue 11, 2013, Pages 810-822

  Li, Yiqiao ^a   Zhang, Yanyan ^b   Han, Weiwei ^a   Hu, Fengyin ^c   Qian, Yu'e ^d   Chen, Qiang ^a  

^a Beilun People's Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Central Laboratory   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Cuprizone; Multiple sclerosis; Myelin repair; TRO19622

Indexed keywords

CUPRIZONE; MYELIN; OLESOXIME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DEMYELINATION; DRUG MECHANISM; ELECTRON MICROSCOPY; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MEMORY; MORPHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; REMYELINIZATION; SPATIAL LEARNING;

ANIMALS; CHOLESTENONES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84885920071     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.804523     Document Type: Article

References (41)

1. Rammohan KW. Axonal injury in multiple sclerosis. Curr Neurol Neurosci Rep 2003;3:231-7.
2. Kuhlmann T, Lingfeld G, Bitsch A, et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002;125:2202-12.
3. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001;81:871-927.
4. Menn B, Garcia-Verdugo JM, Yaschine C, et al. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 2006;26:7907-18.
5. Bradl M, Lassmann H. Oligodendrocytes: Biology and pathology. Acta Neuropathol 2010;119:37-53.
6. Franklin RJ. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 2002;3:705-14.
7. Zawadzka M, Franklin RJ. Myelin regeneration in demyelinating disorders: New developments in biology and clinical pathology. Curr Opin Neurol 2007;20:294-8.
8. Nait-Oumesmar B, Decker L, Lachapelle F, et al. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 1999;11:4357-66.
9. Jablonska B, Aguirre A, Raymond M, et al. Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nat Neurosci 2010;13:541-50.
10. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 2008;9:839-55.
11. Emery B. Regulation of oligodendrocyte differentiation and myelination. Science 2010;330:779-82.
12. Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006;129:3165-72.
13. Murray PD, McGavern DB, Sathornsumetee S, et al. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. Brain 2001;124:1403-16.
14. Kipp M, Clarner T, Dang J, et al. The cuprizone animal model: New insights into an old story. Acta Neuropathol 2009;118:723-36.
15. Torkildsen O, Brunborg LA, Myhr KM, et al. The cuprizone model for demyelination. Acta Neurol Scand Suppl 2008;188:72-6.
16. Acs P, Kalman B. Pathogenesis of multiple sclerosis: What can we learn from the cuprizone model. Methods Mol Biol 2012;900:403-31.
17. Wu QZ, Yang Q, Cate HS, et al. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J Magn Reson Imaging 2008;27:446-53.
18. Zhang L, Yu W, Schroedter I, et al. Galanin transgenic mice with elevated circulating galanin levels alleviate demyelination in a cuprizone-induced MS mouse model. PLOS One 2012;7:e33901.
19. Wang Y, Wang Q, Haldar JP, et al. Quantification of increased cellularity during inflammatory demyelination. Brain 2011;134:3590-601.
20. Chandran P, Upadhyay J, Markosyan S, et al. Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice. Neuroscience 2012;202:446-53.
21. Yu O, Steibel J, Mauss Y, et al. Remyelination assessment by MRI texture analysis in a cuprizone mouse model.Magn Reson Imaging 2004;22:1139-44.
22. Magalon K, Zimmer C, Cayre M, et al. Olesoxime accelerates myelination and promotes repair in models of demyelination. Ann Neurol 2012;71:213-26.
23. Bordet T, Berna P, Abitbol JL, et al. Olesoxime (TRO19622): A novel mitochondrial-Targeted neuroprotective compound. Pharmaceuticals 2010;3:345-68.
24. Bordet T, Buisson B,Michaud M, et al. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther 2007;322:709-20.
25. Martin LJ. Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis. IDrugs 2010;13:568-80.
26. Clark SL, Ward JW. A variation of the Pal Weigert method for staining myelin sheaths. Stain Technology 1934;2:53-5.
27. Vincze A,Ḿazl ́oM, Seress L, et al. A correlative light and electron microscopic study of postnatal myelination in the murine corpus callosum. Int J Dev Neurosci 2008;26:575-84.
28. Traboulsee AL, Li DK. The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol 2006;98:125-46.
29. Zhang J, Jones MV, McMahon MT, et al. In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum. Magn Reson Med 2012;67:750-9.
30. Deloire MS, Ruet A, Hamel D, et al. MRI predictors of cognitive outcome in early multiple sclerosis. Neurology 2011;76:1161-7.
31. LeeMA, Smith S, Palace J, et al. Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. Brain 1998;121:2095-102.
32. Chandran P, Upadhyay J, Markosyan S, et al. Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice. Neuroscience 2012;202:446-53.
33. Hasegawa M, Houdou S, Mito T, et al. Development of myelination in the human fetal and infant cerebrum: A myelin basic protein immunohistochemical study. Brain Dev 1992; 14:1-6.
34. Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003;349:139-45.
35. Tejada-Simon MV, Zang YC, Hong J, et al. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003;53:189-97.
36. Kiernan JA. Histochemistry of staining methods for normal and degenerating myelin in the central and peripheral nervous systems. J Histotechnol 2007;30:87-106.
37. Bayliss HO. Lipid histochemistry (royal microscopical society: Microscopy handbooks 06). Oxford: Oxford University Press; c1984, p46-8.
38. Cook HC. Manual of histological demonstration techniques. London: Butterworths; c1974, p159-63.
39. D'Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 2001;36:60-90.
40. Saab BJ, Saab AMP, Roder JC. Statistical and theoretical considerations for the platform re-location water maze. J Neurosci Meth 2011;198:44-52.
41. Yang L, Guo YM, Han TZ, et al. Age-specific impairment of morris water maze performance following neonatal exposure to magnetic resonance image in rats. Curr Neurovasc Res 2007;4:1-7.